Probably Not The Best Week To Announce This ! Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

6 months ago

Press Release Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced the publication of its patent application under the international Patent Cooperation Treaty (“PCT”) for […]